Zobrazeno 1 - 6
of 6
pro vyhledávání: '"João Henrique Picado Madalena, Santos"'
Autor:
Giovanna Pastore Meneguetti, João Henrique Picado Madalena Santos, Karin Mariana Torres Obreque, Christiano Marcello Vaz Barbosa, Gisele Monteiro, Sandra Helena Poliselli Farsky, Adriano Marim de Oliveira, Claudia Blanes Angeli, Giuseppe Palmisano, Sónia Patrícia Marques Ventura, Adalberto Pessoa-Junior, Carlota de Oliveira Rangel-Yagui
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0224592 (2019)
[This corrects the article DOI: 10.1371/journal.pone.0211951.].
Externí odkaz:
https://doaj.org/article/ec9d5b86d4e147158c0721c52d46a70b
Autor:
Giovanna Pastore Meneguetti, João Henrique Picado Madalena Santos, Karin Mariana Torres Obreque, Christiano Marcello Vaz Barbosa, Gisele Monteiro, Sandra Helena Poliselli Farsky, Adriano Marim de Oliveira, Claudia Blanes Angeli, Giuseppe Palmisano, Sónia Patrícia Marques Ventura, Adalberto Pessoa-Junior, Carlota de Oliveira Rangel-Yagui
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0211951 (2019)
L-asparaginase (ASNase) from Escherichia coli is currently used in some countries in its PEGylated form (ONCASPAR, pegaspargase) to treat acute lymphoblastic leukemia (ALL). PEGylation refers to the covalent attachment of poly(ethylene) glycol to the
Externí odkaz:
https://doaj.org/article/5db8af36663d44a9ae74798958813f0c
Autor:
Larissa Pereira Brumano, Francisco Vitor Santos da Silva, Tales Alexandre Costa-Silva, Alexsandra Conceição Apolinário, João Henrique Picado Madalena Santos, Eduardo Krebs Kleingesinds, Gisele Monteiro, Carlota de Oliveira Rangel-Yagui, Brahim Benyahia, Adalberto Pessoa Junior
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 6 (2019)
L-Asparaginase (ASNase) is a vital component of the first line treatment of acute lymphoblastic leukemia (ALL), an aggressive type of blood cancer expected to afflict over 53,000 people worldwide by 2020. More recently, ASNase has also been shown to
Externí odkaz:
https://doaj.org/article/3b42ba4ad6e14b53b58583ec4ea24b82
Autor:
João Henrique Picado Madalena Santos, Karin Mariana Torres-Obreque, Giovanna Pastore Meneguetti, Beatriz Panichi Amaro, Carlota Oliveira Rangel-Yagui
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 54, Iss spe (2018)
The covalent attachment of polyethylene glycol (PEG) to therapeutical proteins is an important route to develop biobetters for biomedical, biotech and pharmaceutical industries. PEG conjugation can shield antigenic epitopes of the protein, reduce deg
Externí odkaz:
https://doaj.org/article/eb71b76fa3334fa19e4d81ad857d457e
Autor:
Rominne Karla Barros, Freire, Carlos Miguel Nóbrega, Mendonça, Rafael Bertelli, Ferraro, Ignacio Sánchez, Moguel, Aldo, Tonso, Felipe Rebello, Lourenço, João Henrique Picado Madalena, Santos, Lara Durães, Sette, Adalberto, Pessoa Junior
Publikováno v:
Preparative biochemistrybiotechnology. 51(3)
L-asparaginase (ASNase) is an essential drug in the treatment of acute lymphoblastic leukemia (ALL). Commercial bacterial ASNases increase patient survival, but the consequent immunological reactions remain a challenge. Yeasts ASNase is closer to hum
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Biblioteca Digital de Teses e Dissertações da USP
Universidade de São Paulo (USP)
instacron:USP
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Biblioteca Digital de Teses e Dissertações da USP
Universidade de São Paulo (USP)
instacron:USP
Protein PEGylation is the covalent bonding of polyethylene glycol (PEG) polymers to amino acid residues of the protein and it is one of the most promising techniques for improving the therapeutic effect of biopharmaceuticals and long-term stability o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ac6eef02c04c280b8139f6e855c2507